Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

NCT02626845 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.

NCT NCT02626845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02626845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Lead sponsor
Hospital for Special Surgery, New York
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2015
Completion date
July 31, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

granulomatosis with polyangiitis (wegener's granulomatosis)